Manufacturing

Articles

The new cell-line producing platform enables fully scalable production of high-performance adeno-associated virus vectors.

Cevec Launches ELEVECTA Platform for AAV Vectors for Gene Therapy

The goal of the collaboration is to manufacture up to one billion does per year of mRNA-1273, Moderna’s vaccine against the novel coronavirus.

Lonza, Moderna Form Global Collaboration to Manufacture Moderna’s COVID-19 Vaccine

Solentim and ATUM will bundle together the Leap-In Transposase platform with the VIPS single cell cloning instrument for cell line development.

Solentim, ATUM Parnter on Cell Line Development

Dutch company HALIX has announced it is joining a consortium of partners that are all under the guidance of the University of Oxford to provide good manufacturing practice (GMP) manufacturing services for a COVID-19 vaccine.


HALIX Joins Consortium of Partners to Provide GMP Services for COVID-19 Vaccine

This milestone achievement will allow the companies to move forward with developing a GMP-compliant manufacturing process for clinical testing.

Immutep, Batavia Biosciences Generate High-Yielding LAG-3 Cell Line

Joseph Reckamp is an analytics engineer at Seeq Corp., where he specializes in pharmaceutical applications. He received BS and MS degrees in chemical engineering from Villanova University and has worked at companies that include GlaxoSmithKline and Evonik.

Advanced analytics and modeling can be used to predict downstream failures, allowing for corrective action before batches are lost. 


Using Online Transition Analysis to Predict Chromatography Column Failure

The new patented process results in uniform, scalable production and the ability to deliver cell cargo similar to natural exosomes/extracellular vesicles.

Orgenesis, ExcellaBio Announce Breakthrough Manufacturing Process for Bioxomes

Emergent BioSolutions will help develop and manufacture an oral vaccine candidate and will develop plasma-based antibody therapeutics.

Emergent BioSolutions to Manufacture Oral Vaccine and Develop Antibody Therapeutics for COVID-19

The new BIOSTAT STR Generation 3 with BIOBRAIN bioproduction platform offers process intensification with automated feed and bleed and integrated cell retention functionality.

Sartorius Launches New Automated Single-Use Bioproduction Platform

The technology enables the rapid production of large numbers of recombinant antibodies at 80-mL scale.

Manufacturing, Biologic Drugs